Evaluate the Safety, Tolerability and Pharmacokinetics of BG00010 (Neublastin) Administered to Sciatica Participants
Clinical trial NCT00961766 · COMPLETED
Trial details
- NCT number
- NCT00961766
- Sponsor
- Biogen
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2009-08-01
- Primary completion
- 2012-02-01
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.